Direct human papillomavirus E6 whole-cell enzyme-linked immunosorbent assay for objective measurement of E6 oncoproteins in cytology samples

  • Yi Shan Yang
  • , Karen Smith-McCune
  • , Teresa M. Darragh
  • , Yvonne Lai
  • , Ju Hwa Lin
  • , Ting Chang Chang
  • , Hsiao Yun Guo
  • , Tiea Kesler
  • , Alicia Carter
  • , Philip E. Castle
  • , Shuling Cheng*
  • *Corresponding author for this work

Research output: Contribution to journalJournal Article peer-review

12 Scopus citations

Abstract

A novel, whole-cell enzyme-linked immunosorbent assay (ELISA) based on a non-type-specific anti-human papillomavirus (HPV) E6 antibody was tested on 182 residual cytological specimens. For samples with a designation of more severe than cervical intraepithelial neoplasia grade 3 (CIN3+), 83% tested positive for E6; in a subset with paired testing for E6 ELISA and HPV DNA, 72% tested E6 positive and 92% tested high-risk (HR)-HPV DNA positive (P=0.2). Among the women with a less than CIN3 diagnosis, 31% and 47% tested positive for E6 and HR-HPV DNA, respectively (P=0.0006).

Original languageEnglish
Pages (from-to)1474-1479
Number of pages6
JournalClinical and Vaccine Immunology
Volume19
Issue number9
DOIs
StatePublished - 09 2012
Externally publishedYes

Fingerprint

Dive into the research topics of 'Direct human papillomavirus E6 whole-cell enzyme-linked immunosorbent assay for objective measurement of E6 oncoproteins in cytology samples'. Together they form a unique fingerprint.

Cite this